Finepoint Capital LP’s purchase of 684,829 additional RXO shares, lifting its position above 10 million shares, comes alongside management comments about improving full truckload volumes and an outlook for sequential profitability gains in the second quarter.
See our latest analysis for RXO.
RXO’s share price has been on a strong run, with a 30 day share price return of 30.6%, a 90 day share price return of 55.6% and a year to date share price return of 99.2%. The 1 year total shareholder return of 68.3% hints at momentum building around the story.
If this kind of move has you looking beyond a single trucking broker, it could be a good time to scan other opportunities through our screener for 20 top founder-led companies
With RXO’s share price nearly doubling year to date, a value score of 4, and an estimated intrinsic value implying a 47.6% discount, an important question arises: is there still a buying opportunity here, or is the market already pricing in future growth?
RXO last closed at $25.58, while the most followed narrative sees fair value at about $15.85, creating a wide gap that frames the debate.
RXO's relentless investment in AI-powered, proprietary digital freight-matching technology is rapidly boosting employee productivity (up 45% in two years) and driving operating leverage. As digital adoption accelerates in logistics, this sets up sustainable margin and EBITDA growth, making the current valuation disconnect notable.
Curious what kind of revenue path and margin rebuild would need to justify today’s price, especially with a higher future earnings multiple in the mix. The narrative spells out those assumptions.
Result: Fair Value of $15.85 (OVERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, there are still clear watchpoints, including ongoing softness in the automotive sector and execution risk around the large-scale Coyote and tech platform integration.
Find out about the key risks to this RXO narrative.
The narrative based fair value of $15.85 points to RXO looking 61.4% overvalued at $25.58, yet the SWS DCF model points the other way, with a future cash flow value of $48.85. When two methods disagree this much, which one do you think better reflects the risks?
Look into how the SWS DCF model arrives at its fair value.
The split views on RXO’s value and outlook make this a good moment to act quickly, review the data, and shape your own stance, starting with the 2 key rewards and 1 important warning sign
If RXO has sharpened your focus, do not stop here. Use this momentum to broaden your watchlist with a few targeted, high conviction stock ideas.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com